Navigation Links
Studies Decipher How Anti-Smoking Drugs Work
Date:1/3/2011

MONDAY, Jan.3 (HealthDay News) -- Two drugs that help people stop smoking -- bupropion and varenicline -- may change the way the brain reacts to seeing someone else smoke, new studies report.

And that may be how they cut cravings.

Bupropion (Wellbutrin, Zyban) is prescribed around the world to help people resist smoking cues. But it has not been clear how the drug does this. Using brain scans, Christopher S. Culbertson, of the University of California, Los Angeles, and his colleagues examined what happened in the brains of 30 smokers who took the drug or a placebo for eight weeks.

The researchers gauged how much the participants craved cigarettes by asking them to respond after watching "neutral" cues that did not involve smoking or 45-second videos of actors and actresses smoking.

Those who took the drug instead of the placebo reported less craving. They also showed less activity in areas of the brain linked to craving.

"These results demonstrate that treatment with bupropion is associated with an improved ability to resist cue-induced craving and a reduction in cue-induced activation of limbic and prefrontal brain regions," the study authors wrote.

In a second study, Teresa Franklin of the University of Pennsylvania and her colleagues used brain scans to study how the brains of 22 smokers reacted when they took the drug varenicline (Chantix) or a placebo for three weeks. The participants watched 10-minute videos, some of which included smoking cues.

Those who took the drug had less brain activity in some areas and reported less craving after they saw the videos designed to provide smoking cues.

"The results of our study reveal a distinctive new action of varenicline that may contribute to its clinical efficacy," the researchers wrote. "Unsuccessful smoking cessation is more prevalent in individuals with psychiatric illness, suggesting that they have greater difficulty quitting. Varenicline and other medications that can reduce both withdrawal and cue reactivity may be of special benefit to these subgroups."

Both studies were published online Jan. 3 in the Archives of General Psychiatry.

More information

The American Cancer Society has information on quitting smoking.

-- Randy Dotinga

SOURCE: Archives of General Psychiatry, news release, Jan. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New trial studies link between stroke and atrial fibrillation
2. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
3. Studies highlight role of stem cell transplant procedures for blood cancer treatment
4. 2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients
5. Drug-like compound stops thyroid overstimulation in early NIH studies
6. Laboratory studies show promise for new multiple sclerosis treatment
7. A Little Alcohol May Help the Heart: Studies
8. Studies validate use of family health history as gold standard in disease risk assessment
9. Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
10. Practice-changing studies on how oncologists treat cancer to be presented at ASTRO Annual Meeting
11. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies Decipher How Anti-Smoking Drugs Work
(Date:2/11/2016)... Ore. (PRWEB) , ... February 11, 2016 , ... ... Medicaid coverage results in significantly higher rates of several common cancer screenings, especially ... resulting in better outcomes and survival rates. , The study,“What Does Medicaid ...
(Date:2/10/2016)... York, NY (PRWEB) , ... February 10, 2016 , ... ... campaign to celebrate and raise awareness of Nestlé KITKAT as the first global confectionery ... the lives of cocoa farmers and the quality of their product, through activities that ...
(Date:2/10/2016)... PA (PRWEB) , ... February 10, 2016 , ... As ... offer two webinars in February 2016. Each webinar features a dynamic expert and ... to benefit their athletes, patients and facilities. Both events are free to attend, ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Emergency rooms ... harder to find. Unfortunately, this can leave patients with dental emergencies at risk of ... is now offering emergency dental care. , Common dental emergencies include:, ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... San Diego, will bring together more than 200 of the country’s top healthcare ... the future. , “The true benefit of the Forum is the provider-centric perspective, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... A Worldwide Clinical Trials expert will ... Victoria Park Plaza in London , 24-25 ... and future advances for late phase research on Wednesday, 24 ... , associate director of project management at Worldwide, will focus ... regulations and standards in late phase research. ...
(Date:2/10/2016)... Feb. 10, 2016  LexisNexis® Risk Solutions, a ... announced the launch of LexisNexis Provider Performance ... helps improve and optimize the quality and efficiency ... using severity-adjusted scores. By measuring provider performance through ... to deliver better outcomes, improve the patient experience ...
(Date:2/10/2016)... Feb. 10, 2016 Mast Therapeutics, Inc. ... clinical-stage therapies for sickle cell disease and heart failure, ... of 29,090,910 units at a price to the public ... share of the Company,s common stock and one warrant ... at an exercise price of $0.42 per share. The ...
Breaking Medicine Technology: